Fred Davids, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 |
Mr. Toby Allen Brown, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5000 S 13th St, Leavenworth, KS 66048 Phone: 913-727-4845 |
Michael Wayne Lemke, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Dwight E. Eisenhower Medical Center, 4101 S. 4th Street Trafficway, Leavenworth, KS 66048 Phone: 913-682-2000 Fax: 913-758-4109 |
Grace Kim, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 390 Limit St, Leavenworth, KS 66048 Phone: 913-651-2323 Fax: 913-680-1294 |
Mr. Paul Richard Walker, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4101 South 4th Street Trfwy, Leavenworth, KS 66048 Phone: 913-682-2000 Fax: 913-758-4109 |
David K Ellison Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5000 S 13th St, Leavenworth, KS 66048 Phone: 913-727-4864 |
Dr. Patricia J Metcalf, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5000 S 13th St, Leavenworth, KS 66048 Phone: 913-727-4845 |
Mrs. Amelia Alexander Schneider, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5000 S 13th St, Leavenworth, KS 66048 Phone: 913-727-4872 |
Carolyn M. Woodburn, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5000 S 13th St, Leavenworth, KS 66048 Phone: 913-727-4845 |
Joshua Nathan Mcclure, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5000 S 13th St, Leavenworth, KS 66048 Phone: 785-350-1540 |
Nealy Renee Lutz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 |
Kevin Buchwitz Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5000 S 13th St, Leavenworth, KS 66048 Phone: 913-727-4853 |
Dr. Emily Mae Potter, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 |
Dr. Barbara Ray Stephen, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4820 S 4th St, Leavenworth, KS 66048 Phone: 913-727-2255 Fax: 913-727-6530 |
Dr. Mitchell William Bowen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1300 Metropolitan Ave, Leavenworth, KS 66048 Phone: 913-682-8700 |
Dr. Lynn Marie Thomas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 S 4th St, Leavenworth, KS 66048 Phone: 913-651-2027 Fax: 913-651-2008 |
Dr. Eva Schaffner, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 25126 Tonganoxie Rd, Leavenworth, KS 66048 Phone: 252-665-3089 |
Eugene A. Handza, M.H.A., R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5000 S 13th St, Leavenworth, KS 66048 Phone: 913-727-4876 |
Roy S Rasmussen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5000 S 13th St, Leavenworth, KS 66048 Phone: 913-727-4820 |
Dr. April F Ruzicka, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Pharmacy Service-119, Leavenworth, KS 66048 Phone: 913-682-2000 |
News Archive
Scientists supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at the National Institutes of Health have created two mouse strains that will permit researchers to trace, in a live animal, the activity of an enzyme believed to play a crucial role both in the normal immune response as well as autoimmunity and B cell tumor development.
Parkinson's disease sufferers have a different microbiota in their intestines than their healthy counterparts, according to a study conducted at the University of Helsinki and the Helsinki University Central Hospital. Researchers are now trying to determine what the connection between intestinal microbes and Parkinson's disease is.
VIVUS, Inc. today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents are the second, third, and fourth patents to be granted in a series of patent applications VIVUS has filed that are directed to the Qnexa product and methods of using Qnexa in various therapeutic applications.
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon Merck KGaA's initiation of a Phase 1b clinical trial of IMO-2055 (EMD 1201081), an agonist of Toll-like Receptor 9 (TLR9), in combination with cisplatin, fluorouracil and cetuximab (Erbitux®) in first-line treatment of patients with squamous cell carcinoma of the head and neck (SCCHN).
› Verified 6 days ago